C07C 275/30
Being further substituted by halogen atoms, or by nitro or nitroso groups
Official title: being further substituted by halogen atoms, or by nitro or nitroso groups
C07C275/30 (Being further substituted by halogen atoms, or by nitro or nitroso groups) appears on 269 US grants and 305 published applications in this corpus.
Search patents in C07C- Granted patents
- 269
- Published applications
- 305
- Assignees
- 198
- Inventors
- 1,085
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 7 | 0 |
| 1981 | 3 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 7 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 5 |
| 2002 | 3 | 12 |
| 2003 | 7 | 18 |
| 2004 | 8 | 18 |
| 2005 | 8 | 21 |
| 2006 | 8 | 12 |
| 2007 | 6 | 9 |
| 2008 | 12 | 21 |
| 2009 | 8 | 17 |
| 2010 | 9 | 9 |
| 2011 | 8 | 5 |
| 2012 | 8 | 14 |
| 2013 | 8 | 13 |
| 2014 | 13 | 10 |
| 2015 | 8 | 16 |
| 2016 | 11 | 12 |
| 2017 | 6 | 13 |
| 2018 | 12 | 14 |
| 2019 | 8 | 7 |
| 2020 | 9 | 12 |
| 2021 | 8 | 17 |
| 2022 | 6 | 9 |
| 2023 | 4 | 9 |
| 2024 | 5 | 6 |
| 2025 | 4 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heterodimers of glutamic acid27 Jan 2026US 12,534,429 B2Molecular Insight Pharmaceuticals, Inc.
- Diarylureas as CB1 allosteric modulators15 Jul 2025US 12,358,869 B2Research Triangle Institute
- Substituted bisphenylalkylurea compounds and methods of treating breast cancer24 Jun 2025US 12,338,204 B2Texas Tech University System
- Fatty acid analogues and methods of use25 Mar 2025US 12,258,324 B2
- Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto14 Jan 2025US RE50,267 E1Arena Pharmaceuticals, Inc.
- Bromodomain inhibitors for cancer therapy18 Jun 2026US 2026/0167646 A1University of Tennessee Research Foundation
- Urea-based ice recrystallization inhibitor compounds and compositions, and uses thereof for cryopreservation28 May 2026US 2026/0146238 A1PanTHERA CryoSolutions Inc.
- Chiral spirocyclic compounds and methods of preparation and use thereof17 Jul 2025US 2025/0229262 A1The Hong Kong University of Science and Technology
- Diazonium compounds and methods of use for dna cleavage29 May 2025US 2025/0170265 A1New York University
- Substituted bisphenylalkylurea compounds and methods of treating breast cancer15 May 2025US 2025/0154098 A1Texas Tech University System
Most cited
By later US patents
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Amino acid analogs112US 4,880,938 AMerck & Co., Inc. · 1989
- 9-substituted minocycline compounds83US 6,846,939 B2Paratek Pharmaceuticals, Inc. · 2005
- Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof78US 7,476,399 B2Senomyx, Inc. · 2009
- Herbicidal hydantoins66US 4,944,791 AShell Internationale Research Maatschappij B. V. · 1990